⏩️ www.guiaprioam.com
¡Te necesitamos!
El uso prudente de los antibióticos es responsabilidad de todos. Durante toda esta semana, no te pierdas nuestros vídeos para hacer un uso prudente de los antibióticos.
💪🏻 ¡La lucha contra las resistencias empieza en tu consulta!
#EAAD #WAAW #AMSsky
¡Te necesitamos!
Durante toda esta semana, no te pierdas nuestra serie de vídeos prácticos para hacer un uso prudente de los antibióticos en tus pacientes ambulatorios
👊🏻 La lucha contra las resistencias, empieza en tu consulta
#EAAD #WAAW #AMSsky #MedSky #PharmSky #SomosHUVR
Mantente atento a las redes de @hospitaluvrocio.bsky.social y @guiaprioam.bsky.social durante la semana que viene.
Tenemos un mensaje para ti… 😉
#EAAD #WAAW #AMSsky #SomosHUVR
Mantente atento a las redes de @hospitaluvrocio.bsky.social y @guiaprioam.bsky.social durante la semana que viene.
Tenemos un mensaje para ti… 😉
#EAAD #WAAW #AMSsky #SomosHUVR
Our team is now wrapping up follow-up and polishing databases. Hope to have results ready in the first half of 2026!
Hats off to this awesome research team! 🥳
#AMSsky #IDsky @seimc.bsky.social @ciberisciii.bsky.social @ibis-investigacion.bsky.social
Our team is now wrapping up follow-up and polishing databases. Hope to have results ready in the first half of 2026!
Hats off to this awesome research team! 🥳
#AMSsky #IDsky @seimc.bsky.social @ciberisciii.bsky.social @ibis-investigacion.bsky.social
In our latest systematic review in @eclinicalmed.bsky.social, we discuss which interventions work, evidence gaps and future research priorities for SOT.
🔓 www.sciencedirect.com/science/arti...
#IDSky #AMSsky #TxID
Thread below! 🧵(1/6) 👇🏻
In our latest systematic review in @eclinicalmed.bsky.social, we discuss which interventions work, evidence gaps and future research priorities for SOT.
🔓 www.sciencedirect.com/science/arti...
#IDSky #AMSsky #TxID
Thread below! 🧵(1/6) 👇🏻
We are honoured to see some of our research cited to help shape these recommendations! 😃
#AMSsky #IDsky #UTIsky @hospitaluvrocio.bsky.social @ibis-investigacion.bsky.social bsky.app/profile/jose...
[Spoiler: Yes!]
🆓🔓Our recent article on #OralIsTheNewIV! 👉🏻 journals.asm.org/doi/10.1128/...
Food for thought for #AMSsky #IDSky
We are honoured to see some of our research cited to help shape these recommendations! 😃
#AMSsky #IDsky #UTIsky @hospitaluvrocio.bsky.social @ibis-investigacion.bsky.social bsky.app/profile/jose...
doi.org/10.1093/jaca...
#JACAMRNews #IDSky
doi.org/10.1093/jaca...
#JACAMRNews #IDSky
How do we know that today's carbapenem use will lead to a superbug tomorrow?
Why worry about resistance decades later, when I have a patient to worry about now. #IDSky
academic.oup.com/cid/article/...
How do we know that today's carbapenem use will lead to a superbug tomorrow?
Why worry about resistance decades later, when I have a patient to worry about now. #IDSky
academic.oup.com/cid/article/...
In our latest systematic review in @eclinicalmed.bsky.social, we discuss which interventions work, evidence gaps and future research priorities for SOT.
🔓 www.sciencedirect.com/science/arti...
#IDSky #AMSsky #TxID
Thread below! 🧵(1/6) 👇🏻
In our latest systematic review in @eclinicalmed.bsky.social, we discuss which interventions work, evidence gaps and future research priorities for SOT.
🔓 www.sciencedirect.com/science/arti...
#IDSky #AMSsky #TxID
Thread below! 🧵(1/6) 👇🏻
Only 2️⃣4️⃣ patients left to complete the trial!
An amazing team doing an amazing work! 🤩🔝
#IDSky #AMSsky #TeamPride
Only 2️⃣4️⃣ patients left to complete the trial!
An amazing team doing an amazing work! 🤩🔝
#IDSky #AMSsky #TeamPride
www.bradspellberg.com/shorter-is-b...
www.bradspellberg.com/shorter-is-b...
Standard 14d treatments for exacerbations lack good evidence support.
This small RCT favors shorter durations such as 8d 👉🏻 publications.ersnet.org/content/erj/... #IDsky @bradspellberg.bsky.social
Standard 14d treatments for exacerbations lack good evidence support.
This small RCT favors shorter durations such as 8d 👉🏻 publications.ersnet.org/content/erj/... #IDsky @bradspellberg.bsky.social
karger.com/neo/article/...
www.idse.net/Review-Artic...
karger.com/neo/article/...
www.idse.net/Review-Artic...
(🧵1/3) #AMSky #IDsky #TxID
Epidemiology, Treatment, and Outcomes of Gram-Negative Bacteremia in Solid Organ Transplant Recipients #IDsky
onlinelibrary.wiley.com/doi/full/10....
A lot to do for stewies in this field yet!
Let’s get to work #AMSky & #TxID! 💪🏼
Epidemiology, Treatment, and Outcomes of Gram-Negative Bacteremia in Solid Organ Transplant Recipients #IDsky
onlinelibrary.wiley.com/doi/full/10....
aspiration pneumonitis resolves in 24-48h; if symptoms persist >48h, treat aspiration pneumonia with CTX
CTX covers key oral anaerobes (eg Peptostreptococcus) so extended anaerobe coverage is usually unnecessary
avoid piptaz first-line & reserve for resistant cases
aspiration pneumonitis resolves in 24-48h; if symptoms persist >48h, treat aspiration pneumonia with CTX
CTX covers key oral anaerobes (eg Peptostreptococcus) so extended anaerobe coverage is usually unnecessary
avoid piptaz first-line & reserve for resistant cases
@micromunidad.bsky.social
¿Hasta qué punto importa la duración del tratamiento antibiótico? 🧐
open.spotify.com/episode/4yak31…
Hilo con claves y artículos 📚👇#AMSskyk#IDskyky
@micromunidad.bsky.social
¿Hasta qué punto importa la duración del tratamiento antibiótico? 🧐
open.spotify.com/episode/4yak31…
Hilo con claves y artículos 📚👇#AMSskyk#IDskyky
n=315 RCTs
85% demonstrated equivalence or non-inferiority of shorter therapy
Only 7% in ICU, 14% in LMIC, and 15% low risk of bias
academic.oup.com/jacamr/artic...
n=315 RCTs
85% demonstrated equivalence or non-inferiority of shorter therapy
Only 7% in ICU, 14% in LMIC, and 15% low risk of bias
academic.oup.com/jacamr/artic...
In her fantastic talk at #ESCMIDglobal, @valerievaughnmd.bsky.social showed how >90% of antibiotic duration excess occurs post-discharge!
The ROADhome framework can be helpful for this task 👉🏻 academic.oup.com/cid/article/... #IDSky
In her fantastic talk at #ESCMIDglobal, @valerievaughnmd.bsky.social showed how >90% of antibiotic duration excess occurs post-discharge!
The ROADhome framework can be helpful for this task 👉🏻 academic.oup.com/cid/article/... #IDSky
#AMSsky #IDSky
Vol. 1: go.bsky.app/7KcDc2n
Vol. 2: go.bsky.app/2qsEveQ
#AMSsky #IDSky
Vol. 1: go.bsky.app/7KcDc2n
Vol. 2: go.bsky.app/2qsEveQ
Short-term vs long term abx treatment for nocardia infections
#OncID #idsky
Short-term vs long term abx treatment for nocardia infections
#OncID #idsky
#AMSSky
academic.oup.com/cid/advance-...
#AMSSky
academic.oup.com/cid/advance-...
@absteward.bsky.social for finding a new oral vs. IV osteo RCT! Primary endpoint was re surgery. But, 2nd endpoints = treatment failure, recurrence, and non-union. Similar oral vs. IV outcomes for all outcomes. So this is the 10th RCT now, added to table. bradspellberg.com/oral-antibio...
@absteward.bsky.social for finding a new oral vs. IV osteo RCT! Primary endpoint was re surgery. But, 2nd endpoints = treatment failure, recurrence, and non-union. Similar oral vs. IV outcomes for all outcomes. So this is the 10th RCT now, added to table. bradspellberg.com/oral-antibio...